Lucintel anticipates that cancer biomarker will be the fastest growing region in the North America market


   October 24, 2019
According to a new market report published by Lucintel, the future of the cancer biomarker market looks promising with opportunities in the diagnostics, research, prognostics, and risk assessment applications. The cancer biomarker market is expected to grow with a CAGR of 12% from 2019 to 2024. The major growth drivers for this market are growing demand of early diagnosis with accurate and consistent results, growing incidence of cancer, increasing use of cancer biomarker in drug discovery and development, and rising research on cancer biomarker.

To download report brochure, please go to https://www.lucintel.com/cancer-biomarker-market.aspx and click "report brochure" tab

In this market, omics, imaging, immunoassays, cytogenetics, and bioinformatics are the major profiling technologies used to produce biomarkers which enhance cancer detection and facilitate high-speed noninvasive diagnosis. Omics technology is expected to witness the highest growth as it enables faster acquisition of genomic, proteomic, and metabolomic data.

Breast cancer, lung cancer, colorectal cancer, prostate cancer, non-hodgkin’s lymphoma, melanoma, leukemia, thyroid cancer, bladder cancer, and kidney cancer are the major cancer types of the cancer biomarker market. Breast cancer is the largest application due to the high prevalence of breast cancer, increased awareness about breast cancer diagnosis, and increasing research focus on breast cancer.

North America is the largest region over the forecast period due to high incidence rate of cancer, growth in awareness on cancer.

Thermo Fisher Scientific, Roche Diagnostics, Qiagen N.V., Illumina, Agilent Technologies, Biomérieux, Merck & Co., Abbott Laboratories, Becton Dickinson, and Quest Diagnostics are among the major manufacturers of the cancer biomarker market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the cancer biomarker market by biomolecules type, cancer type, profiling technology, method, application, and region. Lucintel has prepared a comprehensive research report titled "Cancer Biomarker Market 2019-2024: Trends, Forecast, and Opportunity Analysis". The Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the cancer biomarker market by biomolecules type, cancer type, profiling technology, method, application, and region as follows:

By Profiling Technology [$M shipment analysis for 2013 – 2024]:



  • Omics


  • Imaging Technologies


  • Immunoassays


  • Cytogenetics


  • Bioinformatics


By Biomolecules Type [$M shipment analysis for 2013 – 2024]:



  • Protein Biomarker


  • Genetic Biomarker


  • Other Cancer Biomarker


By Cancer Type [$M shipment analysis for 2013 – 2024]:



  • Breast Cancer


  • Lung Cancer


  • Colorectal Cancer


  • Prostate Cancer


  • Thyroid Cancer


  • Kidney Cancer


  • Other Cancers


By Method [$M shipment analysis for 2013 – 2024]:



  • Sample Preparation


  • Assay Development


  • Biomarkers and Testing


 By Application [$M shipment analysis for 2013 – 2024]:



  • Diagnostics


  • Research


  • Prognostics


  • Risk Assessment


  • Others


By Region [$M shipment analysis for 2013 – 2024]:



  • North America


    • United States


    • Canada


    • Mexico




  • Europe


    • UK


    • Germany


    • Italy




  • Asia Pacific


    • China


    • Japan


    • India




  • Rest of the World


This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/cancer-biomarker-market.aspx or helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.


Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Market Research Reports

Aerospace & Defense [51]
Chemical [258]
Composites & Advanced Materials [159]
Construction & Industrial [68]
Consumer and Retail [120]
Economic Analysis [86]
Energy & Utility [73]
Finance & Services [10]
Healthcare [62]
Media & Entertainment [16]
Metals & Mining [17]
Technology & Telecommunication [162]
Transportation [140]

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti

Quick Query

Lucintel Insights in News

Follow us on